| Source: |
| Type: |
| PFK (Phosphofructokinase) is a key enzyme in glycolysis, the process by which cells convert glucose into energy. PFK is overexpressed in many types of cancer, and its expression is often associated with poor prognosis. Mechanisms: • PFK promotes glycolysis, which is a key metabolic pathway in cancer cells. • PFK helps to produce energy for cancer cells. • PFK promotes cell proliferation. Therapeutic Targeting: • PFK inhibitors are being developed as a potential therapeutic strategy for cancer treatment. • Inhibitors of glycolysis, such as 2-deoxyglucose, are being explored as a potential therapeutic strategy for cancer treatment. |
| 2272- | dietMet, | Methionine restriction - Association with redox homeostasis and implications on aging and diseases |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:945 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid